Match each diagnostic laboratory profile with the most likely etiology of thyrotoxicosis.
- Decreased TSH, increased free T4, decreased radioactive iodine uptake (RAIU), undetectable serum thyroglobulinExogenous levothyroxine intake
- Decreased TSH, increased free T4, decreased radioactive iodine uptake (RAIU), elevated serum thyroglobulinSubacute granulomatous thyroiditis
- Decreased TSH, increased free T4, increased radioactive iodine uptake (RAIU) with a diffuse, homogeneous patternGraves disease
- Normal or elevated TSH, increased free T4, increased alpha-subunit to TSH molar ratioTSH-secreting pituitary adenoma
Answer
Exogenous levothyroxine intake matches the profile of low RAIU and undetectable thyroglobulin. Subacute granulomatous thyroiditis matches low RAIU and elevated thyroglobulin. Graves disease matches diffusely increased RAIU. A TSH-secreting pituitary adenoma matches central hyperthyroidism with an increased alpha-subunit.
The diagnosis of thyrotoxicosis relies on a structured laboratory algorithm. Primary hyperthyroidism presents with a suppressed TSH and elevated Free T4. Within this category, high radioactive iodine uptake (RAIU) indicates new hormone synthesis (e.g., Graves disease with a diffuse pattern). Low RAIU indicates release of preformed hormone or an exogenous source. These are distinguished by serum thyroglobulin, which is released from damaged follicles in destructive thyroiditis (elevated) but suppressed in exogenous hormone ingestion (undetectable). Conversely, central hyperthyroidism presents with a normal or elevated TSH despite high Free T4; TSH-secreting adenomas typically also hypersecrete the alpha-subunit.
Step-by-Step Solution
Key Concept
Diagnostic evaluation of thyrotoxicosis using thyroid function tests, radioactive iodine uptake, and serum markers.